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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERTargeting PCSK9 for the Treatment of Dyslipidemia 1401Daniel Urban, Janine Pöss, Michael Böhm, Ulrich Laufs
Loss-of-function mutations of the proprotein convertase subtilisin/kexin type 9 (PCSK9) are
associated with low plasma low-density lipoprotein cholesterol (LDL-C) levels. PCSK9
reduces the hepatic uptake of LDL-C by increasing the endosomal and lysosomal
degradation of LDL receptors. Experimental studies indicate that PCSK9 might accelerate
atherosclerosis by promoting inﬂammation, endothelial dysfunction, and hypertension.
Urban and colleagues review the biology of PCSK9 and summarize current therapeutic
strategies targeting PCSK9. Clinical trials of monoclonal antibodies to PCSK9 are currently
being conducted, and these will help to identify both the therapeutic beneﬁts and any
potential dangers of targeting PCSK9 to reduce LDL-C and cardiovascular risk.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYMeta-Analysis of Thrombectomy for Primary PCI 1409
Dharam J. Kumbhani, Anthony A. Bavry, Milind Y. Desai, Sripal Bangalore, Deepak L. Bhatt
Kumbhani and colleagues conducted an updated meta-analysis of the utility of thrombectomy
before primary percutaneous coronary intervention (PCI). By combining the 18 randomized
studies that compared aspiration thrombectomy to standard primary PCI, they showed
reductions in major adverse cardiac event (MACE) and all-cause mortality rates, with
favorable trends for several other endpoints. Combining the 7 studies of mechanical
thrombectomy showed no beneﬁt of mechanical thrombectomy over primary PCI. These
results show that thrombectomy during acute myocardial infarction by manual catheter
aspiration, but not mechanically, is beneﬁcial in reducing MACE and mortality compared
with conventional percutaneous coronary intervention alone.
Editorial Comment: Prakash Balan, H. Vernon Anderson, p. 1419(continued on page A-30)
OCTOBER 15, 2013 (continued) A-30CORONARY REVASCULARIZATIONComplete Revascularization Is Associated With Improved Outcomes 1421
Santiago Garcia, Yader Sandoval, Henri Roukoz, Selcuk Adabag, Mariana Canoniero,
Demetris Yannopoulos, Emmanouil S. Brilakis
Garcia and colleagues performed a systematic review and meta-analysis of studies comparing
complete revascularization (CR) versus incomplete revascularization (IR) in patients with
multivessel coronary artery disease. A total of 35 studies were identiﬁed, including almost
90,000 subjects. The deﬁnitions of IR and CR were not standardized across studies; rather,
the original study deﬁnitions were used. IR was more common after percutaneous coronary
intervention than coronary artery bypass grafting (56% vs. 25%). Relative to IR, CR was
associated with lower long-term risks of each of the following endpoints: mortality,
myocardial infarction, and repeat coronary revascularization. The mortality beneﬁt associated
with CR was consistent across studies irrespective of revascularization modality. Although
this is not a randomized trial, these results suggest that achieving CR has important clinical
advantages.
Editorial Comment: Dean J. Kereiakes, p. 1432ATHEROSCLEROSISCirculating Leukocyte Microparticles Identify Unstable Carotid Plaques 1436
Gabrielle Sarlon-Bartoli, Youssef Bennis, Romaric Lacroix, Marie Dominique Piercecchi-Marti,
Michel A. Bartoli, Laurent Arnaud, Julien Mancini, Audrey Boudes, Emmanuelle Sarlon,
Benjamin Thevenin, Aurelie S. Leroyer, Christian Squarcioni, Pierre Edouard Magnan,
Françoise Dignat-George, Florence Sabatier
Better techniques are needed to identify which patients with asymptomatic carotid stenosis
are at risk for neurological events. Sarlon-Bartoli and colleagues analyzed whether plasma
levels of leukocyte-derived microparticles (LMP) could identify patients with unstable
plaques. Forty-two patients with >70% carotid stenosis had blood drawn prior to carotid
endarterectomy, and the excised plaques were then examined histologically. The median
LMP levels were signiﬁcantly higher in patients with unstable plaque features compared with
those with stable plaque features. After logistic regression, the presence of neurological
symptoms (odds ratio [OR]: 49) and the level of CD11bCD66b+microparticles (OR: 24)
independently predicted plaque instability. These results suggest that measuring LMP may
be useful for identifying which carotid stenosis patients are at high risk for subsequent
neurological events.
Editorial Comment: Jian-Guo Wang, Elena Aikawa, Masanori Aikawa, p. 1442(continued on page A-32)
OCTOBER 15, 2013 (continued) A-32ATHEROSCLEROSISSerum HSP27 Levels Represent a Potential Therapeutic Target for Atherosclerosis 1446
Tara A. Seibert, Benjamin Hibbert, Yong-Xiang Chen, Katey Rayner, Trevor Simard, Tieqiang Hu,
Charles M. Cuerrier, Xiaoling Zhao, Jacqueline de Belleroche, Benjamin J. W. Chow, Steven Hawken,
Kumanan R. Wilson, Edward R. O’Brien
Seibert and colleagues performed a series of both human and animal studies to evaluate the
potential of serum heat shock protein 27 (HSP27) as a therapeutic target in coronary artery
disease (CAD). In a study of low- to intermediate-risk human subjects undergoing either
computed tomography or conventional angiography, there was a strong relationship between
serum HSP27 levels and both baseline CAD and later cardiac risk. In 2 distinct mouse
atherosclerosis models, increasing serum HSP27 levels attenuated the development of
de novo atherosclerotic lesions and shifted plaques to a more stable morphology. These
results suggest that raising HSP27 levels may inhibit atherosclerosis progression and the risk
of plaque rupture.
Editorial Comment: Neal L. Weintraub, Jack Rubinstein, p. 1455HEART RHYTHM DISORDERSAntioxidants May Help to Prevent Post-Operative Atrial Fibrillation 1457Ramón Rodrigo, Panagiotis Korantzopoulos, Mauricio Cereceda, René Asenjo, Jaime Zamorano,
Eli Villalabeitia, Cristián Baeza, Rubén Aguayo, Rodrigo Castillo, Rodrigo Carrasco,
Juan G. Gormaz
Rodrigo and colleagues performed a randomized trial to determine if pre-operative n-3 fatty
acids and antioxidant vitamin supplementation could reduce the incidence of post-operative
atrial ﬁbrillation (POAF) after cardiac surgery. Two hundred patients scheduled for on-pump
cardiac surgery were randomized to placebo or supplementation with n-3 polyunsaturated
fatty acids (eicosapentaenoic acid to docosahexaenoic acid ratio of 1:2), vitamin C, and
vitamin E. POAF occurred in 9.7% of patients in the supplemented group versus 32% in the
placebo group. Early after surgery, placebo patients had higher biomarkers of inﬂammation
and oxidative stress. This safe, well-tolerated, and low-cost regimen, consisting of n-3
polyunsaturated fatty acids plus vitamins C and E supplementation, markedly reduced the
likelihood of POAF.(continued on page A-34)
OCTOBER 15, 2013 (continued) A-34HEART RHYTHM DISORDERSMitochondrial Dysfunction Increases the Risk of POAF 1466
David Montaigne, Xavier Marechal, Philippe Lefebvre, Thomas Modine, Georges Fayad,
Helene Dehondt, Christopher Hurt, Augustin Coisne, Mohamed Koussa, Isabelle Remy-Jouet,
Farid Zerimech, Eric Boulanger, Dominique Lacroix, Bart Staels, Remi Neviere
Montaigne and colleagues investigated whether a causal link exists between post-operative
atrial ﬁbrillation (POAF) and pre-operative function of cardiac mitochondria. Pre-operative
mitochondrial respiration and calcium retention capacity, respiratory complex activity, and
myocardial oxidative stress were quantiﬁed in right atrial tissue from 104 consecutive patients
with metabolic syndrome undergoing coronary artery bypass graft surgery. Decreased
pre-operative mitochondrial respiration and increased sensitivity to calcium-induced
mitochondrial permeability transition pore opening were signiﬁcantly associated with POAF.
Gene expression proﬁle analysis identiﬁed a general down-regulation of the mitochondria/
oxphos gene cluster in pre-operative atrial tissue of patients who developed AF. These results
provide novel insights into the link between mitochondrial function and atrial arrhythmias.
Editorial Comment: David A. Brown, Fatiha Moukdar, p. 1474CARDIAC IMAGINGCTP Quantiﬁcation Improves the Accuracy of CTA 1476Matthias Rief, Elke Zimmermann, Fabian Stenzel, Peter Martus, Karl Stangl, Johannes Greupner,
Fabian Knebel, Anisha Kranz, Peter Schlattmann, Michael Laule, Marc Dewey
Rief and colleagues tested whether adding myocardial computed tomography perfusion
(CTP) would improve the diagnostic accuracy of computed tomography angiography (CTA)
in patients with previous coronary stenting. The CTA and CTP were performed in
91 consecutive patients with stents before quantitative coronary angiography. Signiﬁcantly
more patients were nondiagnostic for stent assessment by CTA (22%) versus CTP (1%).
The per-patient diagnostic accuracy of CTA/CTP (87%) was signiﬁcantly higher than that
of CTA alone (71%). CTA/CTP had a signiﬁcantly lower effective radiation dose than
angiography. When combined, coronary CTA and myocardial CTP improve diagnosis
of coronary artery disease and in-stent restenosis in patients with previous coronary stents
compared with CTA alone.
Editorial Comment: Andrew E. Arai, p. 1486
